| 10(4) |
L13 |
ZORBAX TMS |
Assay |
Reprinted 11(1), 11(5) |
| 16(1) |
L1 |
LiChrosorb RP-18 |
Assay |
{ Alternative reagent |
| 16(1) |
L1 |
Vydac 218TP54 |
Assay |
See Insulin |
| 10(1) |
L13 |
ZORBAX TMS |
Chromatographic assay |
Desamido Insulin and Insulin-related substances;deleted 10(4) |
| 10(1) |
L13 |
ZORBAX TMS |
Chromatographic assay |
Insulin Human; deleted 10(4) |
| 16(1) |
L20 |
Zorbax GF250 |
Chromatographic purity |
Test B: High molecular weight proteins; see Insulin Chromatographic purity Test B |
| 16(1) |
L1 |
Vydac 218TP54 |
Chromatographic purity |
Test A: Insulin related substances; see Insulin Chromatographic purity Test A |
| 10(4) |
L13 |
ZORBAX TMS |
Content (minor) of . . . . |
desamido insulin and insulin related substances; reprinted 11(1), 11(5); deleted 16(1) |
| 10(4) |
L13 |
ZORBAX TMS |
Identity |
See Assay |
| 18(6) |
L1 |
LiChrosorb RP-18 |
Identity |
See Assay; 5-µm; Method A; { Alternative reagent |
| 18(6) |
L7 |
Zorbax C8 150A |
Identity |
See Assay; Method B |
| 16(1) |
L1 |
Vydac 218TP54 |
Identity |
Test A; see Assay |
| 16(1) |
L7 |
Zorbax C8 150A |
Identity |
Test B; HPLC Fingerprint Analysis |
| 18(6) |
L20 |
Zorbax GF250 |
Limit of . . . . . . . . . |
high molecular weight proteins; see Insulin |
| 18(6) |
L1 |
LiChrosorb RP-18 |
Related compounds |
See Insulin; 5-µm; { Alternative reagent |